Conference Coverage: ASCO 2020 Breast Cancer Highlights

Expert perspectives on the latest therapeutic developments, treatment approaches, and implications for clinical decision-making coming out of the ASCO 2020 conference. How will emerging research affect treatment paradigms, ongoing clinical trials, and the development of new compounds?

Faculty Chair

Adam Brufsky, MD, PhD

Medical Director, Magee-Womens Cancer Program at the UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Look Inside This Report

Download a sample of this report and start discovering the insights:

REPORT INCLUDES STRATEGIC RECOMMENDATIONS AND KEY TAKEAWAYS ON

  • Evolving Therapies for Hormone Receptor-Positive Breast Cancer
  • New Therapeutic Approaches for Early Stage and Metastatic HER2+ Breast Cancer
  • Advances in Triple-Negative Breast Cancer
  • Insights Into Immune-Based and Chemotherapy for Breast Cancer

 

For a full overview of the key topics that will be covered during the live meeting as well as information on how to purchase the report, click the link below:

Expert Faculty

Pierfranco Conte, MD
University of Padua, Padua, Italy

William Gradishar, MD
Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Nadia Harbeck, MD, PhD
Ludwig-Maximilians-University of Munich LMU – Breast Center, Germany

Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, TX, USA

Mark D. Pegram, MD
Stanford Cancer Institute,
Stanford, CA, USA

Explore Available and Upcoming Insight Reports

View Reports